{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:03:46Z","timestamp":1770347026436,"version":"3.49.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Central compartment atopic disease (CCAD) is a subtype of chronic rhinosinusitis with nasal polyps (CRSwNP), distinguished by polypoid changes in the middle turbinates, superior nasal septum, and\/or superior turbinates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to compare the efficacy of combined azelastine\/ fluticasone propionate spray (Azeflu) with fluticasone propionate nasal spray (FP) for management of CCAD after endoscopic sinus surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present work is a prospective, randomized, double-blinded study that included 48 patients, who underwent endoscopic surgery for refractory CCAD. The patients were randomly enrolled into two groups using simple randomization. Group A patients received FP (50\u00a0\u03bcg per spray) twice daily, while group B patients received Azeflu spray (137\/50\u00a0\u03bcg, Aze\/FP per spray) twice daily. Outcome measures included clinical assessment (SNOT-22), Lund Mackay radiologic score (LM), total serum IgE, nasal mucosa eosinophil count, and polyps score, and need for revision surgery. The results were collected before surgery as well as 6 and 12 months after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SNOT-22 scores, total serum IgE, and nasal mucosa eosinophil count decreased significantly in both groups at the end of follow-up period. The decrease was significantly greater in group B patients who received the combined spray. On the other hand, there was a modest decrease in LM scores at 6 and 12 months after surgery in both groups. The frequency of polyps recurrence was significantly less in group B than in group A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present research shows that nasal sprays may effectively reach the target areas in the central compartment after surgery, potentially benefiting from the widened post-surgical nasal corridor. Combined steroid\/H1 blocker sprays provided better postoperative control of CCAD than steroid sprays. The synergistic action of H1 blockers in the combined sprays confirms the association between CCAD and nasal allergy and encourages us to consider it as a first line treatment for the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1732886","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:01:00Z","timestamp":1770296460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined azelastine fluticasone nasal spray versus fluticasone propionate nasal spray in postoperative management of central compartment atopic disease (CCAD)"],"prefix":"10.3389","volume":"17","author":[{"given":"Samy","family":"Elwany","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Alexandria Faculty of Medicine","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Aly","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Alexandria Faculty of Medicine","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Elwany","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Research Institute","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihad","family":"Tousson-Abouelazm","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Kholief","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Alexandria Faculty of Medicine","place":["Alexandria, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/JAA.S238421","article-title":"Evaluation of in vitro penetration of fluticasone propionate from MP-AzeFlu and fluticasone propionate nasal spray through EpiAirwayTM606 tissues using vertical diffusion cells","volume":"13","author":"Berger","year":"2020","journal-title":"J. Asthma Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0974-7788.59946","article-title":"Sample size calculation","volume":"1","author":"Bhalerao","year":"2010","journal-title":"Int. J. Ayurveda Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jaci.2016.03.025","article-title":"MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis","volume":"138","author":"Bousquet","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","article-title":"Allergic rhinitis","volume":"6","author":"Bousquet","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B5","first-page":"519","article-title":"Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities","volume-title":"Otolaryngol. Head. Neck Surg.","author":"Brunner","year":"2017"},{"key":"B6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2500\/ajra.2017.31.4443","article-title":"Central compartment atopic disease","volume":"31","author":"DelGaudio","year":"2017","journal-title":"Am. J. Rhinol. Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/lio2.32","article-title":"A review of classification schemes for chronic rhinosinusitis with nasal polyposis endotypes","volume":"1","author":"Dennis","year":"2016","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/01945998221082554","article-title":"A prospective analysis of systemic and local aeroallergen sensitivity in central compartment atopic disease","volume":"167","author":"Edwards","year":"2022","journal-title":"Otolaryngology - Head Neck Surg. (United States)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/ejo.ejo_63_17","article-title":"Arabic translation and validation of SNOT-22","volume":"33","author":"Elwany","year":"2017","journal-title":"Egypt. J. Otolaryngology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","author":"Fokkens","year":"2020","journal-title":"Rhinology Journal"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/lary.27180","article-title":"Allergic phenotype of chronic rhinosinusitis based on radiologic pattern of disease","volume":"128","author":"Hamizan","year":"2018","journal-title":"Laryngoscope"},{"key":"B12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.otohns.2007.02.004","article-title":"The lund-mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?","volume":"137","author":"Hopkins","year":"2007","journal-title":"Otolaryngology - Head Neck Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"27534030231217423","DOI":"10.1177\/27534030231217423","article-title":"Central compartment atopic disease and its surgical outcomes: olfactory changes and technical notes","volume":"14","author":"Huang","year":"2023","journal-title":"Ther. Adv. Allergy Rhinology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0187835","DOI":"10.1371\/journal.pone.0187835","article-title":"Criterion validity of 8-item morisky medication adherence scale in patients with asthma","volume":"12","author":"Jane\u017ei\u010d","year":"2017","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.2147\/DDDT.S226575","article-title":"Chronic rhinosinusitis with nasal polyps: targeting IgE with Anti-IgE omalizumab therapy","volume":"14","author":"Kariyawasam","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1159\/000516417","article-title":"MP-AzeFlu in moderate-to-severe allergic rhinitis: a literature review","volume":"182","author":"Klimek","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/JAA.S350837","article-title":"Chinese central compartment atopic disease: the clinical characteristics and cellular endotypes based on whole-slide imaging","volume":"15","author":"Kong","year":"2022","journal-title":"J. Asthma Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ohn.1019","article-title":"Refractory chronic coh: a state-of-the-art review for otolaryngologists","volume":"172","author":"Lilly","year":"2024","journal-title":"Otolaryngology - Head Neck Surg. (United States)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2500\/ajra.2015.29.4231","article-title":"Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population","volume":"29","author":"Lou","year":"2015","journal-title":"Am. J. Rhinol. Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00405-014-3191-3","article-title":"Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis","volume":"272","author":"Luo","year":"2015","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/lio2.236","article-title":"The relationship between allergy and chronic rhinosinusitis","volume":"4","author":"Marcus","year":"2018","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7020030","article-title":"Chronic rhinosinusitis: does allergy play a role?","volume":"7","author":"Marcus","year":"2019","journal-title":"Med. Sci. (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/alr.22454","article-title":"Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps","volume":"10","author":"Marcus","year":"2020","journal-title":"Int. Forum Allergy Rhinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1465-9921-12-23","article-title":"Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells","volume":"12","author":"Mullol","year":"2011","journal-title":"Respir. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1002\/alr.21695","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int. Forum Allergy Rhinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/JAA.S98172","article-title":"A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US","volume":"9","author":"Prenner","year":"2016","journal-title":"J. Asthma Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1002\/lary.24654","article-title":"Modification of the lund-kennedy endoscopic scoring system improves its reliability and correlation with patient-reported outcome measures","volume":"124","author":"Psaltis","year":"2014","journal-title":"Laryngoscope"},{"key":"B28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jaci.2022.10.026","article-title":"The joint task force on practice parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis","volume":"151","author":"Rank","year":"","journal-title":"J. Allergy Clin. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"16611","DOI":"10.20452\/pamw.16611","article-title":"Recent guidelines addressing chronic rhinosinusitis with nasal polyps: practical aspects","volume":"133","author":"Rank","year":"","journal-title":"Pol. Arch. Intern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13223-018-0311-4","article-title":"Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers","volume":"14","author":"Roca-Ferrer","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/alr.21290","article-title":"Polypoid changes of the middle turbinate as an indicator of atopic disease","volume":"4","author":"White","year":"2014","journal-title":"Int. Forum Allergy Rhinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/alr.21258","article-title":"The association between allergy and chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations","volume":"4","author":"Wilson","year":"2014","journal-title":"Int. Forum Allergy Rhinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1159\/000513312","article-title":"Changes in clinical and histological characteristics of nasal polyps in northern China over the past 2-3 decades","volume":"182","author":"Yu","year":"2021","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:01:01Z","timestamp":1770296461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":33,"alternative-id":["10.3389\/fphar.2026.1732886"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1732886","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"article-number":"1732886"}}